Form 4 · Filed Jun 25, 2026, 08:05 PM UTC
GLUE/Monte Rosa Therapeutics, Inc.
Janku Filip — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | M | other | 30,000 | $8 | $226,800 | 89,992 |
| Jun 24, 2026 | S | sell | 30,000 | $21 | $642,681 | 59,992 |
| Jun 24, 2026 | M | other | 30,000 | — | — | 66,000 |
| Jun 23, 2026 | M | other | 6,000 | $8 | $45,360 | 71,837 |
| Jun 23, 2026 | S | sell | 11,845 | $20 | $239,522 | 59,992 |
| Jun 23, 2026 | M | other | 6,000 | — | — | 96,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-282740